Viking Therapeutics, Inc.VKTX

Market cap

$4B

P/E ratio

	2015/12	2016/12	2017/12	2018/12	2019/12	2020/12	2021/12	2022/12	2023/12	2024/12
Cash and cash equivalents	768,550	3	9	25	8	29	26	37	56	27
Marketable securities, current	13	10	12	277	267	439	176	119	307	876
Total cash & short-term investments	14	13	21	302	276	468	202	155	362	903
Total current assets	15	14	22	302	284	256	211	167	367	907
Total non-current assets	237,455	560,879	269,613	0	1	0	0	1	1	1
Total assets	15	15	22	302	284	257	211	169	368	908
Accounts payable	592,414	1	2	1	2	4	1	9	8	10
Total current liabilities	2	6	9	5	7	12	9	22	19	27
Total non-current liabilities	5	16,307	-	0	0	0	-	1	1	1
Total liabilities	7	6	9	5	7	12	9	23	20	28
Common stock and paid-in capital	97	208	358	0	0	0	0	0	0	0
Retained earnings	-45,545,445	-60,277,267	-80,854,932	-103	-129	-168	-223	-292	-378	-488
Stockholders' equity	9	8	13	298	277	244	202	145	348	880